Tumour Volume of the Index Lesion in Prostate Cancer: Correlation between Results of Multiparametric Magnetic Resonance Imaging and the Histophatology
DOI:
https://doi.org/10.17140/UAOJ-4-134Keywords:
Prostate cancer, magnetic resonance imaging (MRI), Radical prostatectomy, Index lesion, Tumour volume, (International Society of Urological Pathology (ISUP)Abstract
Introduction
Prostate cancer is generally multifocal, presenting a lesion with a dominant focus (index lesion) that is characterized by being the
lesion with the greatest volume and the biological capacity of invasion to adjacent tissues and distant metastases. With the advent
of focal therapy and organ preservation in prostate cancer, it is essential to know the real tumour volume and thus, avoid the per
sistence of disease after treatments with curative intent. The aim of this study is to correlate the results of the dominant tumour
volume obtained from the multiparametric magnetic resonance imaging (MRI) of the prostate and the histopathology.
Material and Methods
A retrospective study was performed which included all radical prostatectomies (RP) with previous MRI. A comparative analysis
was performed between the tumour volume obtained from the MRI and the histopathology.
Results
A total of 46 patients were included in the study. The sensibility of the MRI in diagnosing the index lesion was 82.6%, highlight
ing that all tumours with a Gleason score ≥ 4+3 were diagnosed. The mean tumour volume in the MRI was 14.3 mm and in the
histological result was 18.82 mm (p<0.05). The estimation tumour volume concordance was greatest in higher risk (International
Society of Urological Pathology (ISUP)).
Conclusion
The MRI underestimates the real tumour volume of the prostate cancer index lesion when compared to the histological result of
the surgical piece, being significantly lower in high-risk lesions.
References
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013; 49: 1374–1403. doi: 10.1016/j.ejca.2012.12.027
Lavallee LT, Binette A, Witiuk K, Cnossen S, Mallick R, Fergusson DA, et al. Reducing the harm of prostate cancer screening: repeated prostate-specific antigen testing. Mayo Clin Proc. 2016; 91: 17-22. doi: 10.1016/j.mayocp.2015.07.030
Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P, et al. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 2016; 375: 1415-1424. doi: 10.1056/NEJMoa1606220
EAU guidelines 2019: Web site. https://uroweb.org/guideline/ prostate-cancer/?type=summary-of-changes. Accessed October 1, 2020.
Ahmed H, Arya M, Freeman A, Emberton M. Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? Lancet Oncol. 2012; 13: e509-e517. doi: 10.1016/ S1470-2045(12)70388-1
Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000; 100: 57-70. doi: 10.1016/s0092-8674(00)81683-9
Bott SR, Ahmed HU, Hindley RG, Abdul-Rahman A, Freeman A, Emberton M. The index lesion and focal therapy: An analysis of the pathological characteristics of prostate cancer. BJU Int. 2010; 106: 1607-1611. doi: 10.1111/j.1464-410X.2010.09436.x
Ahmed HU. The index lesion and the origin of prostate cancer. N 54 Rico L et al Engl J Med. 2009; 361: 17041706. doi: 10.1056/NEJMcibr0905562
Rosenkrantz AB, Deng FM, Kim S, Lim RP, Hindman N, Mussi TC, et al. Prostate cancer: Multiparametric MRI for index lesion localization- - a multiple-reader study. AJR Am J Roentgenol. 2012; 199: 830-837. doi: 10.2214/AJR.11.8446
Mazaheri Y, Hricak H, Fine SW, Akin O, Shukla-Dave A, Ishill NM, et al. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: Correlation with pathologic tumor volume. Radiology. 2009; 252: 449-457. doi: 10.1148/radiol.2523081423
Turkbey B, Mani H, Aras O, Rastinehad AR, Shah V, Bernardo M, et al. Correlation of magnetic resonance imaging tumor volume with histopathology. J Urol. 2012; 188: 1157-1163. doi: 10.1016/j. juro.2012.06.011
Villers A, Puech P, Mouton D, Leroy X, Ballereau C, Lemaitre L. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: Correlation with radical prostatectomy findings. J Urol. 2006; 176 (6 Pt 1): 2432-2437. doi: 10.1016/j.juro.2006.08.007
Wise A, Stamey TA, McNeal JE, Clayton JL. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology. 2002; 60: 264-269. doi: 10.1016/ s0090-4295(02)01728-4
Stamey TA, McNeal JE, Wise AM, Clayton JL. Secondary cancers in the prostate do not determine PSA biochemical failure in untreated men undergoing radical retropubic prostatectomy. Eur Urol. 2001; 39 (Suppl 4): 22-23. doi: 10.1159/000052577
Karavitakis M, Ahmed HU, Abel PD, Hazell S, Winkler MH. Tumor focality in prostate cancer: Implications for focal therapy. Nat Rev Clin Oncol. 2011; 8: 48-55. doi: 10.1038/nrclinonc.2010.190
Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whitemore AS, Schmid HP. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer. 1993; 71(Suppl 3): 933- 938. doi: 10.1002/1097-0142(19930201)71:3+<933::aid-cncr2820711408>3.0.co;2-l
Wolters T, Roobol M, van Leeuwen J, van der Bergh R, Hoedemaeker R, van Leenders G, et al. A critical analysis of the tumor volume thereshold for clinically insignificant prostate cancer using a data set of randomized screening trial. J Urol. 2011; 185(1): 121-125. doi: 10.1016/j.juro.2010.08.082
Klotz L, Emberton M. Management of low risk prostate cancer – active surveillance and focal therapy. Curr Opin Urol. 2014; 24(3): 270-279. doi: 10.1097/MOU.0000000000000055
Langer DL, van der Kwast TH, Evans AJ, Sun L, Yaffe MJ, Trachtenberg J, et al. Intermixed normal tissue within prostate Original Research | Volume 4 | Number 3| cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2–sparse versus dense cancers. Radiology. 2008; 249: 900-908. doi: 10.1148/radiol.2493080236
Le JD, Tan N, Shkolyar E, Lu DY, Kwan L, Marks LS, et al. Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: Correlation with whole-mount histopathology. Eur Urol. 2015; 67: 569-576. doi: 10.1016/j. eururo.2014.08.079
Le Noblin J, Orcyk C, Deng FM, Melamed J, Rusinek H, Taneja S, et al. Prostate tumour volumes: Evaluation of the agreement between magnetic resonance imaging and histology using novel co-registration software. BJU Int. 2014; 114: E105-E112. doi: 10.1111/bju.12750
Le Noblin J, Rosenkrantz A, Villers A, Orcyk C, Deng FM, Melamed J, et al. Image guided focal therapy for magnetic resonance Submit your article to this journal | https://openventio.org/submit-manuscript/ Original Research | Volume 4 | Number 3| Rico L et al imaging visible prostate cancer: Defining a 3-dimensional treatment margin based on magnetic resonance imaging histology co-registration analysis. J Urol. 2015; 194: 364-370. doi: 10.1016/j. juro.2015.02.080
McNeal JE, Haillot O. Patterns of spread of adenocarcinoma in the prostate as related to cancer volume. Prostate. 2001; 49: 48- 57. doi: 10.1002/pros.1117
Ball MW, Partin AW, Epstein JI. Extent of extraprostatic extension independently in- fluences biochemical recurrence-free survival: Evidence for further pT3 subclassification. Urology. 2015; 85: 161-164. doi: 10.1016/j.urology.2014.08.025
Barqawi AB, Stoimenova D, Krughoff K, Eid K, O'Donnell C, Phillips JM, et al. Targeted focal therapy in the management of organ confined prostate cancer. J Urol. 2014; 192: 749-753. doi: 10.1016/j.juro.2014.03.033
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Urology and Andrology (UA) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
